Europe and US risk being outpaced on innovation, as happened in the car industry, warns Pascal Soriot
AstraZeneca must operate at “Chinese speed” to ensure it doesn’t suffer the fate of the western automotive industry by losing out to more innovative rivals, the drug company’s boss has said.
The FTSE 100 company is watching the rise of China’s pharmaceutical industry closely and collaborating to take drugs to global markets, but its chief executive, Pascal Soriot, said the US and European pharmaceutical sector must focus on increasing the speed of innovation.
Source: The Guardian World — This article was automatically imported from the source. Read full article at original source →
